We are continuously looking to expand our business with the mission of incorporating our research and technology to improve patients’ quality of life and health outcomes globally. Aligning with this, Medlab endeavours to develop collaborative partnerships with innovative businesses in multiple industries and applications. Medlab has a portfolio of ongoing commercial endeavours, where we offer our expertise from concept through supply chain to manufactured end product. We are always looking for Global partnering in the R&D space and licencing our NanoCelle® (drug delivery technology):

  • Into a variety of Generic API’s
  • Into medical-related garments to the production of “smart wearables” based on the triggered release of medication
  • Use in small molecules with solubility problems

We are specifically looking for partners for:

  • Phase III medicinal cannabinoid + Nanocelle® technology: A non opioid analgesic for cancer related bone pain
  • NanoCelle®: A sub-micron delivery platform for small molecule

For partnering enquiries, please enter and submit your information below.